Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Krazati
Marketing
FDA blasts Bristol Myers over misleading Krazati efficacy claims
The FDA has taken Bristol Myers to task for making false or misleading claims about the efficacy of Krazati on the website for the KRAS cancer drug.
Nick Paul Taylor
Aug 8, 2024 10:59am
BMS and Mirati's KRAS inhibitor Krazati moves beyond NSLC
Jun 24, 2024 8:53am
ASCO: BMS' confirmatory KRAS data leave FDA prospects unclear
Jun 1, 2024 8:00am
BMS touts KRAS confirmatory trial win after Amgen's stumble
Mar 29, 2024 10:35am
EU regulators back Mirati's Krazati after initial rebuff
Nov 10, 2023 11:15am
Securities filing details BMS' yearslong courtship of Mirati
Oct 24, 2023 11:41am
